durvalumab,paclitaxel,carboplatin,cisplatin,gemcitabine,pemetrexed
astrazeneca
['lcsm,(-blcsm)', 'durva', 'nsclc', 'lung', 'aegean', 'sclc']
neoadjuvant durvalumab plus chemotherapy followed by adjuvant durvalumab in patients with resectable nsclc: aegean trial #lcsm #lungcancer #immunotherapy #aacr23 
News and views from the world of clinical oncology and hematology